The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
β-Blockers alprenolol and carvedilol stimulate β-arrestin-mediated EGFR transactivation
Open accessAbstract
Recent evidence suggests that binding of agonist to its cognate receptor initiates not only classical G protein-mediated signaling, but also β-arrestin-dependent signaling. One such β-arrestin-mediated pathway uses the β 1-adrenergic receptor (β 1 AR) to transactivate the EGFR. To determine whether β-adrenergic ligands that do not activate G protein signaling (i.e., β-blockers) can stabilize the β 1 AR in a signaling conformation, we screened 20 β-blockers for their ability to stimulate β-arrestin-mediated EGFR transactivation. Here we show that only alprenolol (Alp) and carvedilol (Car) induce β 1 AR-mediated transactivation of the EGFR and downstream ERK activation. By using mutants of the β 1 AR lacking G protein-coupled receptor kinase phosphorylation sites and siRNA directed against β-arrestin, we show that Alp- and Car-stimulated EGFR transactivation requires β 1 AR phosphorylation at consensus G protein-coupled receptor kinase sites and β-arrestin recruitment to the ligand-occupied receptor. Moreover, pharmacological inhibition of Src and EGFR blocked Alp- and Car-stimulated EGFR transactivation. Our findings demonstrate that Alp and Car are ligands that not only act as classical receptor antagonists, but can also stimulate signaling pathways in a G protein-independent, β-arrestin-dependent fashion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poole-Wilson, P. A., Swedberg, K., Cleland, J. G., Di Lenarda, A., Hanrath, P., Komajda, M., Lubsen, J., Lutiger, B., Metra, M., Remme, W. J., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13800-7 · Cited by 1,872
Transduction of Receptor Signals by ß-Arrestins
Lefkowitz, R. J., & Shenoy, S. K. (2005) · Science · doi:10.1126/science.1109237 · Cited by 1,727
Prenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C., & Ullrich, A. (1999) · Nature · doi:10.1038/47260 · Cited by 1,504
β-Arrestin-Dependent Formation of β 2 Adrenergic Receptor-Src Protein Kinase Complexes
Luttrell, L. M., Ferguson, S. S. G., Daaka, Y., Miller, W. E., Maudsley, S., Della Rocca, G. J., Lin, F.-T., Kawakatsu, H., Owada, K., Luttrell, D. K., et al. (1999) · Science · doi:10.1126/science.283.5402.655 · Cited by 1,475
β-Arrestins and Cell Signaling
DeWire, S. M., Ahn, S., Lefkowitz, R. J., & Shenoy, S. K. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.022405.154749 · Cited by 1,397
G PROTEIN–COUPLED RECEPTOR KINASES
Pitcher, J. A., Freedman, N. J., & Lefkowitz, R. J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.653 · Cited by 1,361
β-Adrenergic Receptor Blockade in Chronic Heart Failure
Bristow, M. R. (2000) · Circulation · doi:10.1161/01.cir.101.5.558 · Cited by 1,028
British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary
Williams, B., Poulter, N. R., Brown, M. J., Davis, M., McInnes, G. T., Potter, J. F., Sever, P. S., & Thom, S. M. (2004) · BMJ · doi:10.1136/bmj.328.7440.634 · Cited by 848
Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.
Waagstein, F., Hjalmarson, A., Varnauskas, E., & Wallentin, I. (1975) · Heart · doi:10.1136/hrt.37.10.1022 · Cited by 832
Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds
Luttrell, L. M., Roudabush, F. L., Choy, E. W., Miller, W. E., Field, M. E., Pierce, K. L., & Lefkowitz, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041604898 · Cited by 831
DeFea, K. A., Zalevsky, J., Thoma, M. S., Déry, O., Mullins, R. D., & Bunnett, N. W. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.6.1267 · Cited by 822
β-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the β2 Adrenergic Receptor
Shenoy, S. K., Drake, M. T., Nelson, C. D., Houtz, D. A., Xiao, K., Madabushi, S., Reiter, E., Premont, R. T., Lichtarge, O., & Lefkowitz, R. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m506576200 · Cited by 759
Klotz, K.-N., Hessling, J., Hegler, J., Owman, C., Kull, B., Fredholm, B. B., & Lohse, M. J. (1997) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/pl00005131 · Cited by 723
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
Wisler, J. W., DeWire, S. M., Whalen, E. J., Violin, J. D., Drake, M. T., Ahn, S., Shenoy, S. K., & Lefkowitz, R. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707936104 · Cited by 597
Self-citationAhn, S., Shenoy, S. K., Wei, H., & Lefkowitz, R. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405878200 · Cited by 508
β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection
Noma, T., Lemaire, A., Naga Prasad, S. V., Barki-Harrington, L., Tilley, D. G., Chen, J., Le Corvoisier, P., Violin, J. D., Wei, H., Lefkowitz, R. J., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31901 · Cited by 418
Self-citationRen, X.-R., Reiter, E., Ahn, S., Kim, J., Chen, W., & Lefkowitz, R. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409534102 · Cited by 331
Ghanouni, P., Steenhuis, J. J., Farrens, D. L., & Kobilka, B. K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101126198 · Cited by 311
Hoffmann, C., Leitz, M. R., Oberdorf-Maass, S., Lohse, M. J., & Klotz, K.-N. (2004) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-003-0860-y · Cited by 304
Catecholamines, Cardiac β-Adrenergic Receptors, and Heart Failure
Lefkowitz, R. J., Rockman, H. A., & Koch, W. J. (2000) · Circulation · doi:10.1161/01.cir.101.14.1634 · Cited by 291
Self-citationGalandrin, S., & Bouvier, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026716 · Cited by 291
Swaminath, G., Deupi, X., Lee, T. W., Zhu, W., Thian, F. S., Kobilka, T. S., & Kobilka, B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502352200 · Cited by 257
Fraser, I. D. C., Cong, M., Kim, J., Rollins, E. N., Daaka, Y., Lefkowitz, R. J., & Scott, J. D. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00419-x · Cited by 229
Barnes, W. G., Reiter, E., Violin, J. D., Ren, X.-R., Milligan, G., & Lefkowitz, R. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412924200 · Cited by 194
Self-citationAhn, S., Wei, H., Garrison, T. R., & Lefkowitz, R. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c300443200 · Cited by 177
Agonist-receptor efficacy I: mechanisms of efficacy and receptor promiscuity
Kenakin, T. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89020-3 · Cited by 176
Rapacciuolo, A., Suvarna, S., Barki‐Harrington, L., Luttrell, L. M., Cong, M., Lefkowitz, R. J., & Rockman, H. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305675200 · Cited by 156
Self-citationStructure and Conformational Changes in the C-terminal Domain of the β2-Adrenoceptor
Granier, S., Kim, S., Shafer, A. M., Ratnala, V. R. P., Fung, J. J., Zare, R. N., & Kobilka, B. K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611904200 · Cited by 150
Rochais, F., Vilardaga, J., Nikolaev, V. O., Bünemann, M., Lohse, M. J., & Engelhardt, S. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30012 · Cited by 138
Mechanisms of inverse agonism at G-protein-coupled receptors
Strange, P. G. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)01993-4 · Cited by 129
Functional Significance of Oligomerization of G-protein-coupled Receptors
Salahpour, A., Angers, S., & Bouvier, M. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00260-5 · Cited by 124
Are we misunderstanding beta-blockers
Cruickshank, J. M. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.01.069 · Cited by 124
Seifert, R., Wenzel‐Seifert, K., Gether, U., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29653-1 · Cited by 105
Baker, J. G., Hall, I. P., & Hill, S. J. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1312 · Cited by 91
Antiadrenergic Therapy of Chronic Heart Failure
Bristow, M. R. (2003) · Circulation · doi:10.1161/01.cir.0000054530.87613.36 · Cited by 89
EGF Receptor Transactivation Mediated by the Proteolytic Production of EGF-like Agonists
Carpenter, G. F. (2000) · Science s STKE · doi:10.1126/stke.2000.15.pe1 · Cited by 84
Joseph, S. S., Lynham, J. A., Colledge, W. H., & Kaumann, A. J. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-004-0884-y · Cited by 48
Site of Action of β-Ligands at the Human β1-Adrenoceptor
Baker, J. G. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.082875 · Cited by 41
Mizuochi, Y., Okajima, K., Harada, N., Molor-Erdene, P., Uchiba, M., Komura, H., Tsuda, T., & Katsuya, H. (2007) · Translational research · doi:10.1016/j.trsl.2006.11.008 · Cited by 24
Adolfsson, L., Areskog, N., Furberg, C. D., & Johnsson, G. (1974) · European Journal of Clinical Pharmacology · doi:10.1007/bf00561324 · Cited by 24
Cited by
Teaching old receptors new tricks: biasing seven-transmembrane receptors
Rajagopal, S., Rajagopal, K., & Lefkowitz, R. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3024 · Cited by 825
Biased signalling: from simple switches to allosteric microprocessors
Smith, J. S., Lefkowitz, R. J., & Rajagopal, S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.229 · Cited by 738
DeWire, S. M., Yamashita, D. S., Rominger, D. H., Liu, G., Cowan, C. L., Graczyk, T. M., Chen, X.-T., Pitis, P. M., Gotchev, D., Yuan, C., et al. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.201616 · Cited by 647
Self-citationNobles, K. N., Xiao, K., Ahn, S., Shukla, A. K., Lam, C. M., Rajagopal, S., Strachan, R. T., Huang, T.-Y., Bressler, E. A., Hara, M. R., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001707 · Cited by 626
Molecular Mechanism of β-Arrestin-Biased Agonism at Seven-Transmembrane Receptors
Reiter, E., Ahn, S., Shukla, A. K., & Lefkowitz, R. J. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105800 · Cited by 583
Metadata
- Authors
- Kim, I.-M., Tilley, D. G., Chen, J., Salazar, N. C., Whalen, E. J., Violin, J. D., & Rockman, H. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2008-09-23
- Volume
- 105
- Issue
- 38
- Pages
- 14555-14560
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2157687771
- Cited by
- 276
- References
- 40
- FWCI
- 4.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.